Long a quieter, locally focused industry, Japanese pharma giants are increasingly looking to the rest of the world for deals.

If we want higher growth, better wages and improved living standards, we need a plan of action which delivers” – Michelle ...

Yao Pharma's deal with the US pharmaceutical giant underscores China's growing role in global biotech licensing US ...

D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology ...

An organoid standard working group has recently been established, with Chinese scholars leading the effort to gather international expertise to develop a strategic plan and advance standard ...

For decades, Arieh Warshel, USC Distinguished Professor of Chemistry and a 2013 Nobel laureate, has used computer simulations ...

Discover why Terns Pharmaceuticals, Inc. stock is up 770% YTD with strong CML drug data and major upcoming milestones. Click ...

Two years after this, Sakaguchi was able to link these discoveries. He proved that the Foxp3 gene governs the development of ...

The FDA has cleared the first artificial intelligence (AI) drug development tool to help evaluate fatty liver disease in ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

As of Monday, December 08, Legend Biotech Corporation’s LEGN share price has dipped by 8.82%, which has investors questioning if this is right time to buy.

As AI reshapes biotechnology, stakeholders are acting to establish governance to maintain safety and efficacy standards.